What is Yunnan Biovalley Pharmaceutical Co Price-to-Operating-Cash-Flow?
As of today (2024-06-21), Yunnan Biovalley Pharmaceutical Co's share price is ¥7.88.
Yunnan Biovalley Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.02. Hence, Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 7.71.
The historical rank and industry rank for Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
BJSE:833266'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.44 Med: 15.33 Max: 523.57
Current: 7.5
During the past 11 years, Yunnan Biovalley Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 523.57. The lowest was 5.44. And the median was 15.33.
Yunnan Biovalley Pharmaceutical Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥0.41.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.02.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Yunnan Biovalley Pharmaceutical Co was 45.60% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -10.50% per year.
During the past 11 years, Yunnan Biovalley Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 17.70% per year. The lowest was -58.10% per year. And the median was -21.20% per year.
Yunnan Biovalley Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yunnan Biovalley Pharmaceutical Co Price-to-Operating-Cash-Flow Chart
|
Yunnan Biovalley Pharmaceutical Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
9.18 |
444.24 |
- |
9.95 |
|
Yunnan Biovalley Pharmaceutical Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
9.80 |
7.44 |
5.71 |
9.95 |
8.67 |
Competitive Comparison of Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Yunnan Biovalley Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation
Yunnan Biovalley Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 7.88 | / | 1.022 |
| = | 7.71 |
Yunnan Biovalley Pharmaceutical Co's Share Price of today is ¥7.88.
Yunnan Biovalley Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Yunnan Biovalley Pharmaceutical Co (BJSE:833266) Business Description
Traded in Other Exchanges
N/A
Address
No. 999 Biological Valley Street, Majinpu New District, High-tech Zone, Yunnan Province, Kunming City, CHN, 650500
Yunnan Biovalley Pharmaceutical Co Ltd engages in research and development, production, and marketing of pharmaceuticals and health care based on herbal medicines. The products on the market include breviscapine injection, breviscapine Shengmai capsules, breviscapine tablets, breviscapine dripping pills, Erigeron Capsules, Erigeron Soft Capsules.
Yunnan Biovalley Pharmaceutical Co (BJSE:833266) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BJSE:833266 has been successfully added to your